Dong Qian

Weifang Medical University — China

Immunology and Microbiology · Life Sciences

14h-index599citations48works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Aquaculture disease management and microbiota(14), Cancer Immunotherapy and Biomarkers(7), Ferroptosis and cancer prognosis(7), Telomeres, Telomerase, and Senescence(5), Aquaculture Nutrition and Growth(4)

Publications48 total

Correction: Bioinformatic analysis identifies LPL as a critical gene in diabetic kidney disease via lipoprotein metabolism
Frontiers in Endocrinology·2025Open Access
Author response for "<scp>DDX3X</scp> induces mesenchymal transition of endothelial cells by disrupting <scp>BMPR2</scp> signaling"
2025
Correction: Silencing PinX1 enhances radiosensitivity and antitumor-immunity of radiotherapy in non-small cell lung cancer
Journal of Translational Medicine·2025Open Access
Beyond pathogenicity: applications of the type III secretion system (T3SS) of Pseudomonas aeruginosa
Frontiers in Microbiology·2025· 2 citedOpen Access
Survival Benefit of Combined Chemoimmunotherapy and Radiation Therapy in Patients with Recurrent or Metastatic Esophageal Cancer
Advances in Radiation Oncology·2025Open Access
Neoadjuvant chemoradiation with camrelizumab and nimotuzumab for initially inoperable esophageal squamous cell carcinoma: A single-arm phase 2 trial
European Journal of Cancer·2025· 1 cited
Silencing RPL11 attenuates acute kidney injury by suppressing tubular apoptosis and macrophage-driven inflammation
Frontiers in Immunology·2025Open Access
Author response for "<scp>DDX3X</scp> induces mesenchymal transition of endothelial cells by disrupting <scp>BMPR2</scp> signaling"
2025
Short-course hypofractionated radiotherapy of 4 Gy per fraction for limited-stage small cell lung cancer: a randomized pilot trial
Translational Lung Cancer Research·2025Open Access
Bioinformatic analysis identifies LPL as a critical gene in diabetic kidney disease via lipoprotein metabolism
Frontiers in Endocrinology·2025· 2 citedOpen Access
<scp>PC4</scp> Potentially Predicts Chemoradiation‐Induced Antitumor Immunity in Esophageal Squamous Cell Carcinoma
Cancer Science·2025· 1 citedOpen Access
Nanotherapeutic Wee1 Inhibition Sensitizes Tumor Ferroptosis to Promote Cancer Immunotherapy and Abscopal Effect
ACS Nano·2025· 1 cited
LGALS3BP: A Potential Prognostic Biomarker Influencing Antitumor Immunity in Triple-negative Breast Cancer
Current Medicinal Chemistry·2025· 1 cited
Microbiota contribute to regulation of the gut-testis axis in seasonal spermatogenesis
The ISME Journal·2025· 4 citedOpen Access
Disruption of tumor-intrinsic PGAM5 increases anti-PD-1 efficacy through the CCL2 signaling pathway
Journal for ImmunoTherapy of Cancer·2025· 13 citedOpen Access
BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Journal of Translational Medicine·2024· 25 citedOpen Access
Salivary microbiome is associated with the response to chemoradiotherapy in initially inoperable patients with esophageal squamous cell carcinoma
Journal of Oral Microbiology·2024· 2 citedOpen Access
Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy with Helical TomoTherapy Versus Conventional Radiation Therapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicenter, Randomized Phase 3 Trial
International Journal of Radiation Oncology*Biology*Physics·2024· 14 citedOpen Access
Silencing PinX1 enhances radiosensitivity and antitumor-immunity of radiotherapy in non-small cell lung cancer
Journal of Translational Medicine·2024· 6 citedOpen Access
143P Efficacy and safety of aumolertinib (AUM) with radiotherapy versus concurrent chemoradiotherapy (cCRT) in the treatment of unresectable stage III EGFR-mutant NSCLC: A multicenter, randomized, open-label phase III study (ADVANCE)
ESMO Open·2024Open Access
page 1 of 3Next →

Frequent Co-authors

Fei Yin(7), Dan Xie(6), Suming Zhou(6), Rongrong Ma(6), Xiao Xie(5), Jingjing Cheng(5), Yawei Bao(4), Jiasong Xie(4), Lei Liu(3), Yiji Liao(3), Shan Jin(3), Youbin Yu(3), Yuhua Lei(3), Jieping Qiu(3), Huiquan Liu(3), Yuan He(3), Xiaoyang Li(3), Huan Xu(3), Zhouji Shen(3), Jieyong Tian(3)